The news: Through a new partnership with Doctronic, Utah became the first state to utilize AI for automated prescription renewals, specifically for patients seeking refills on existing medications, not initial prescriptions.

• Utah residents can verify their identity and location online and answer questions similar to what a physician would ask to assess prescription refill eligibility, per Politico.
• The program is restricted to 190 commonly prescribed drugs—medications such as painkillers, ADHD drugs, and injectables are excluded.
• Human doctors aren’t involved unless there’s uncertainty about the renewal.
• For now, patients will be charged $4 per Rx renewal handled by Doctronic.

Why it matters: The program challenges the traditional requirement for doctor oversight on every prescription renewal.

• Utah officials and Doctronic cite that the AI matches doctors' renewal decisions 99% of the time and has the potential to boost medication adherence while reducing clinician administrative burden.
• However, the AMA says the lack of physician input poses a real risk to patients and doctors.
• For its part, Doctronic has secured malpractice insurance for its AI, holding the tech to the same accountability standard as a human doctor, Politico reported.

Implications for healthcare AI companies: While pharmacies and tech platforms have already automated the routing of refill requests to doctors, Utah’s program moves toward removing the physician from the loop entirely. Although the AI mirrors standard clinical questions, it lacks a human’s ability to probe for subtle red flags and opens the door for patients to game the system by giving the AI the answer it’s looking for.

As AI shifts from a supportive tool to an active practitioner of medicine, regulatory scrutiny is bound to intensify. This is especially true for companies like Doctronic, whose branding as a "trusted AI doctor" directly challenges traditional medical oversight.

This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.